Cabaletta Bio
Cabaletta Bio's phone number is +1 610 977 2422
.
Cabaletta Bio is a biopharmaceutical company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases. The company's therapeutic platform produces highly selective autologous chimeric autoantibody receptor (CAAR) T cells that bind and destroy only disease-causing B cells while sparing healthy B cells which are essential for human health. Cabaletta has signed an exclusive licensing agreement and partnership with Penn focused on treating B cell-mediated autoimmune diseases with CAAR T cells. Cabaletta was founded by Dr. Micha...
read more
Cabaletta Bio is a biopharmaceutical company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases. The company's therapeutic platform produces highly selective autologous chimeric autoantibody receptor (CAAR) T cells that bind and destroy only disease-causing B cells while sparing healthy B cells which are essential for human health. Cabaletta has signed an exclusive licensing agreement and partnership with Penn focused on treating B cell-mediated autoimmune diseases with CAAR T cells. Cabaletta was founded by Dr. Michael Milone, Dr. Aimee Payne and Dr. Steven Nichtberger. Dr. Milone and Dr. Payne are physicians/scientists at Penn and also serve as co-chairs of Cabaletta’s Scientific Advisory Board. The Company’s lead therapeutic program is a potential treatment for a prototypical B cell-mediated autoimmune disease, mucosal pemphigus Vulgaris (mPV). mPV is a rare skin disorder that causes painful blisters and sores on mucous membranes such as the mouth, nose, throat, and genitals, leading to severe and sometimes debilitating and life-altering effects.
show less
Website | cabalettabio.com | |
Industry | Biotechnology | |
Location | Philadelphia, Pennsylvania, United States | |
Employees | 38 | |
Founded | 2017 |
Phone | +1 610 977 2422 | |
Funding | 88,000,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | cabalettabio.com | |
Industry | Biotechnology | |
Location | Philadelphia, Pennsylvania, United States | |
Employees | 38 | |
Founded | 2017 | |
linkedin.com/company/cabalettabio | ||
Phone | +1 610 977 2422 | |
Funding | 88,000,000 USD |
Email Patterns for Cabaletta Bio
Top Competitors for Cabaletta Bio
Cabaletta Bio Questions
Where are Cabaletta Bio's headquarters?
Cabaletta Bio's headquarters are in
What is Cabaletta Bio's phone number?
Cabaletta Bio's phone number is +1 610 977 2422
What is Cabaletta Bio's official website?
Cabaletta Bio's website is cabalettabio.com
How many employees are working in Cabaletta Bio right now?
Cabaletta Bio has
38 employees.
View the Email and Phone Numbers for all 38 working at Cabaletta Bio.
What is Cabaletta Bio's industry?
Cabaletta Bio's industry is
Biotechnology
Who are Cabaletta Bio's top competitors?
Cabaletta Bio's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are Cabaletta Bio's categories?
Cabaletta Bio's categories are Biotechnology, Health Care, Medical, Robotics, Therapeutics
What is Cabaletta Bio's location?
Cabaletta Bio's location is
Philadelphia, Pennsylvania, United States
When was Cabaletta Bio's founded?
Cabaletta Bio's founding year is 2017
What is Cabaletta Bio's funding?
Cabaletta Bio's funding is 88,000,000 USD
What is Cabaletta Bio's current status?
Cabaletta Bio's current status is ipo
Top Cabaletta Bio Employees
Director Of Gcp Compliance
mjcooper01@gmail.com
+1615-995-9320
Associate Scientist
mallorie.fouch@wuxiapptec.com
+1267-644-5073
Senior Director, Gmp Quality And Compliance
a.markey@adaptimmune.com
+1215-825-9260
Vice President And Controller
logpowell@hotmail.com
+1610-456-9654
Senior Director Gene Transfer Technologies
michael_imboden@iogenetics.com
+1608-310-9540
Senior Director, Gmp Quality And Compliance
phlygrl@gmail.com
+1601-449-0374
Vice President, Clinical Operations
kimhoffman2@verizon.net
+1610-423-6100